Vivos Frumhlutverk: Augnaðgerðakerfi eftir Olcayto Guelec and David Geuder

Hönnunarverkið Vivos Frumhlutverk: Augnaðgerðakerfi eftir Olcayto Guelec and David Geuder er hávirt verðlaunaverk sem hlaut hin virtu 2026 A' Design Award í gulli verðlaun í keppnisflokknum Hönnun lækningatækja og lækningabúnaðar.

GullLækningavara· 2026

Vivos Frumhlutverk: Augnaðgerðakerfi

eftir Olcayto Guelec and David Geuder

Viðskiptavinur: Geuder AG

Handhafi A' Design Award í gulli í flokknum Lækningavara

56,783

Staðfestur verðlaunahafi

Staðfesta verðlaunastöðu fyrir #182492

Skoða hjá A' Design Award Fréttatilkynning Verðlaunamerki

Litir

Hönnunin

Um Vivos Frumhlutverk: Augnaðgerðakerfi

Bókartexti: Vivos endurskilgreinir skurðaðgerðavinnustöðina sem vettvang sem þróast samhliða klínískum metnaði. Þrjár uppsetningar, Core, Nova og Nova+, auka getu án þess að skipta þurfi um kerfi, eina uppfærsluarkitektúrinn sinnar tegundar í augnskurðlækningum. Eitt viðmót, staðfest með 91,7 prósent ánægju við fyrstu notkun án fyrri þjálfunar, endurspeglar hönnun byggða í kringum skurðlækninn frekar en aðgerðina. Upplýstar tengingar tækja, fínunnin efni og hófstillt smáatriði veita tækinu rólega og örugga nærveru, laus við sjónræna truflun sem einkennir flokkinn.

Viðurkenningin

Um A' Design Award í gulli

Vivos Frumhlutverk: Augnaðgerðakerfi vann A' Design Award í gulli, óendanlega virta viðurkenningu sem veitt er fyrsta flokks, dásamlegum og framúrskarandi hönnunarverkum. Sigurvegarar í gulli eru afar nýstárleg, framsýn og töfrandi glæsileg sköpunarverk sem endurspegla snilld, visku og hæfni hönnuða sinna. Þess er vænst að Vivos Frumhlutverk: Augnaðgerðakerfi sé mjög lofuð, brautryðjandi og stórfengleg uppfinning sem skilar fordæmislausu virði. Þetta hönnunarverk sem vann A' Design Award í gulli er stórbrotið, virt verkefni sem gagnast mörkum listar, vísinda, hönnunar og tækni mjög vel og færir þau fram á við. Vivos Frumhlutverk: Augnaðgerðakerfi skapar sterkar þráartilfinningar, vekur ástríðu, hvetur til sköpunar og heillar okkur.

Á bak við hönnunina

Fjölmiðlapakki

Heimildir, hópmeðlimir og tæknilegar upplýsingar frá hönnuðinum.

Einstakar eiginleikar: Vivos is the only ophthalmic surgery system that grows with clinical needs. Core for cataract. Nova adds vitrectomy. Plus adds laser. One platform. One interface. One training investment. Independent usability validation confirmed 92 percent user satisfaction among first time users. Illuminated connection sockets were rated positively by all study participants. Premium materials and restrained detailing give the device a likeable presence without the visual noise typical of the category.
Stærðir og umbúðir: Display: 24 inch capacitive touchscreen. Vitrectomy: up to 40000 cuts per min. Vacuum: up to 700 mmHg, highest in category. Phacoemulsification: 53 kHz piezoelectric. IOP: active real-time (VIVOS Balance). Endolaser: 532 nm. Illumination: SOLEA LED, 16.9M colours, 2 ports, Retina Protection Mode. CE pending, submitted Feb 2026. ISO 13485 2016.
Merki: Ophthalmic Surgery System, Medical Device Design, Phacoemulsification, Vitrectomy, Modular Medical Platform, Surgical Ergonomics, Workflow Design, German Medical Engineering, Usability Validation, Premium Medical Aesthetics
Framleiðslutækni: Medical-grade polycarbonate housing, antimicrobial surface coating rated for over 10,000 disinfection cycles. Piezoelectric phacoemulsification at 53 kHz with beveled-up probe geometry for optimised fluidics. Pneumatic vitrectomy probe up to 40,000 cuts/min. IEC 60601-1 compliant. Modular quick-change cassette - single or multi-patient - tool-free exchange. Compatible with older phaco handpieces, protecting prior investment. Individually assembled in Heidelberg. ISO 13485:2016, IEC 62366-1, IEC 60601-1, CE pending
Hönnunaráskorun: The central challenge was integrating six surgical functions, historically distributed across two to three separate devices, into a single platform without increasing cognitive load. Internally, decades of segmented product architecture and a 75-year heritage required rethinking established engineering logic. Externally, MDR regulations, IEC 62366 1 usability standards and strict OR hygiene constraints limited design freedom. Maintaining identical UX across Core, Nova and Plus while ensuring durability for thousands of cleaning cycles demanded systemic redesign rather than incremental improvement.
Rannsóknir: Usability research was conducted. Objective: reduce cognitive load without limiting clinical capability. Methodology: iterative co-design workshops with surgeons, Geuder teams and engineering, followed by independent summative validation per IEC 62366-1. Data collection included usability testing and task-based evaluations. Participants: 13 first-time users at RWTH Aachen University, 2026. Results: 91.7% satisfaction, no unacceptable residual risks. Insights validated the workflow UI, surgeon profiles and illuminated sockets, contributing to greater efficiency, improved patient safety and long-term system adoption in clinical practice.
Innblástur: Ophthalmic surgery is precise. Why should its devices remain fragmented, complex and visually uninspiring. Anterior and posterior procedures require separate investments, training and ecosystems not because clinical need requires it but because no manufacturer redesigned the architecture around the surgeon. Geuder AG with seventy five years of ophthalmic expertise asked what if one platform could grow without hardware replacement. Validated by independent study and unique in its modular upgrade logic.
Lengd verkefnis: The project was developed in Heidelberg, Germany by Geuder AG. Development spanned multiple months with iterative design and engineering phases conducted in close collaboration with ophthalmic surgeons and operating room nursing staff. Summative usability validation was performed at RWTH Aachen University in early 2026. CE Mark application was submitted on 27 February 2026. Public market launch is scheduled for June 2026.
Verkflæði: Before each procedure, the surgeon selects a personal profile, preloading preferred settings and pedal sensitivity. A three-column touchscreen maps each surgical step as a visual sequence. Colour-coded modules allow instant identification in a darkened theatre. Illuminated sockets guide instrument connection by touch. The foot pedal, with individually adjustable actuation force, controls fluid flow and laser hands-free. Eye pressure is monitored and adjusted in real time.
Liðsmenn: Collaboration between Geuder AG's Engineering, Quality Management, Regulatory Affairs, Product Management, Service, Application, Development, and Sales departments.
Myndheimildir: Photography Geuder AG, 2026